Natural Capsules Ratios

Natural Capsules Ltd Ratios

The Natural Capsules Ltd Ratios page provides a complete fundamental analysis of Natural Capsules Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Natural Capsules Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Natural Capsules Ltd (NSE: NATCAPSUQ, BSE: 524654) is currently trading at ₹151, with a market capitalization of ₹1.56B. As a major player in the Health technology sector and Pharmaceuticals: other industry, Natural Capsules Ltd remains a key stock for fundamental analysis using Natural Capsules Ltd Ratios.

Natural Capsules Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Natural Capsules Ltd P/E ratio currently stands at 293.45, making it one of the most tracked metrics in Natural Capsules Ltd Ratios.

Historically, the Natural Capsules Ltd P/E ratio has shown strong fluctuations:

• 2024: 293.45
• 2023: 51.18
• 2022: 19.76
• 2021: 23.29
• 2020: 9.70

The rising Natural Capsules Ltd P/E ratio indicates increasing investor confidence and premium valuation.

Price to Book Ratio (P/B)

The Natural Capsules Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.82.

Historical P/B trend:

• 2024: 0.82
• 2023: 1.40
• 2022: 2.96
• 2021: 5.21

Natural Capsules Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Natural Capsules Ltd P/S ratio currently stands at 1.07, an important part of Natural Capsules Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 1.07
• 2023: 1.83
• 2022: 2.14
• 2021: 2.40

A stable or declining Natural Capsules Ltd P/S ratio indicates cautious market sentiment.

Natural Capsules Ltd Price to Cash Flow Ratio (P/CF)

The Natural Capsules Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 12.85.

Historical Natural Capsules Ltd Price to Cash Flow Ratio:

• 2024: 12.85
• 2023: 0
• 2022: 22.58
• 2021: 257.46
• 2020: 4.79

The rising Natural Capsules Ltd Price to Cash Flow Ratio indicates premium valuation based on cash flow.

Natural Capsules Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Natural Capsules Ltd EV currently stands at ₹3.05B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 3.05B
• 2023: 4.05B
• 2022: 4.79B
• 2021: 3.7B

Natural Capsules Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Natural Capsules Ltd EV/EBITDA ratio is currently 16.94, a key metric in Natural Capsules Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 16.94
• 2023: 20.91
• 2022: 13.92
• 2021: 14.62

Stable Natural Capsules Ltd EV/EBITDA indicates balanced valuation.

Natural Capsules Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Natural Capsules Ltd D/E ratio is currently 0.45, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.45
• 2023: 0.53
• 2022: 0.79
• 2021: 0.62

Natural Capsules Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Natural Capsules Ltd ROE currently stands at 0.28%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 0.28
• 2023: 3.40
• 2022: 17.89
• 2021: 19.18

Declining ROE indicates pressure on profitability.

Natural Capsules Ltd Ratios Analysis Summary

The Natural Capsules Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Natural Capsules Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Natural Capsules Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.